You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 14, 2025

Sciegen Pharms Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SCIEGEN PHARMS INC, and what generic and branded alternatives to SCIEGEN PHARMS INC drugs are available?

SCIEGEN PHARMS INC has one hundred and four approved drugs.

Summary for Sciegen Pharms Inc

US Patents:	0
Tradenames:	82
Ingredients:	81
NDAs:	104

Drugs and US Patents for Sciegen Pharms Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sciegen Pharms Inc	LISINOPRIL	lisinopril	TABLET;ORAL	208920-001	Mar 4, 2021	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Sciegen Pharms Inc	LEVOCETIRIZINE DIHYDROCHLORIDE	levocetirizine dihydrochloride	TABLET;ORAL	203646-001	Sep 9, 2014	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Sciegen Pharms Inc	HYDROCHLOROTHIAZIDE	hydrochlorothiazide	TABLET;ORAL	203018-001	Jul 23, 2014	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Sciegen Pharms Inc	PRAMIPEXOLE DIHYDROCHLORIDE	pramipexole dihydrochloride	TABLET;ORAL	203855-001	Oct 28, 2014	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Sciegen Pharms Inc	FEXOFENADINE HYDROCHLORIDE ALLERGY	fexofenadine hydrochloride	TABLET;ORAL	204507-002	Sep 16, 2015		OTC	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.